Ten large companies join NIH to speed up drug discovery

Abstract

The Accelerating Medicines Partnership (AMP) launched last February is a bold initiative that partners the National Institutes of Health (NIH), ten biopharma companies and several nonprofit organizations with the overall aim of speeding up drug development in areas deemed too challenging for individual drugmakers.